PODNL1 and central nervous system cancer: Our results are concordant with and validate the known association between PODNL1 mRNA overexpression and unfavorable OS in glioma [19], as we show that methylation of PODNL1 is associated with decreased PODNL1 expression, and specific PODNL1 CpG methylations are associated with significantly improved OS.